POC DNA Test Could Increase Cervical Cancer Screening Access
A low-cost, point-of-care DNA test for HPV infections that was invented at Rice University delivers results in 45 minutes and requires just two pieces of equipment.
Read MorePosted by Melanie Hamilton-Basich | Jun 26, 2023 | Cervical (HPV), Point-of-Care |
A low-cost, point-of-care DNA test for HPV infections that was invented at Rice University delivers results in 45 minutes and requires just two pieces of equipment.
Read MorePosted by Melanie Hamilton-Basich | Jun 20, 2023 | Flu & Respiratory Infections, Point-of-Care |
Sekisui Diagnostics’ OSOM Ultra Plus Flu A&B Test is a rapid antigen test that takes only 10 minutes at the point of care.
Read MorePosted by Melanie Hamilton-Basich | Jun 15, 2023 | Cervical (HPV), Urinalysis & Toxicology |
Self-sampling with the Colli-Pee device could significantly expand access to cervical cancer screening for underserved and rural populations.
Read MorePosted by Melanie Hamilton-Basich | Jun 7, 2023 | Covid 19, Molecular Diagnostics, POC Reagents & Test Kits |
Cue Health has received De Novo authorization from the FDA for its Cue COVID-19 Molecular Test, designed for both home and point-of-care use.
Read MorePosted by Chris Wolski | Jun 2, 2023 | Controls |
Quality controls with lower cardiac troponin concentrations are needed to monitor and validate hs-cTn assay performance.
Read More